LAUREN KEMP: Open Payments
NPI 1336691112 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 34 payments from 9 companies in 2025. Trend: 2023 $1,098 · 2024 $1,307 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $218 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $198 |
| E.R. Squibb & Sons, L.L.C. | 6 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $101 |
| Medtronic, Inc. | 1 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
Products named: VERQUVO, LifeVest, Kerendia, SYMPLICITY G3, CAMZYOS, ELIQUIS, FARXIGA, INSPIRE.
Industry payments across MS — which companies pay providers there.
